Advertisement
Screener

ROCKWELL MEDICAL, INC. (RMTI) Increase (Decrease) in Other Operating Assets

2.8 / 5 stars · 68/120 Roast Me

ROCKWELL MEDICAL, INC. Increase (Decrease) in Other Operating Assets

ROCKWELL MEDICAL, INC. (RMTI) reported Increase (Decrease) in Other Operating Assets of -$1.41 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-21

  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2019-12-31 was -$3.15K, a 101.31% decline year-over-year.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2019-09-30 was -$805.10K.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2019-06-30 was $78.23K, a 91.58% decline year-over-year.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for the quarter ending 2019-03-31 was -$203.98K.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for fiscal 2023 was -$1.41M.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for fiscal 2022 was -$2.72M.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for fiscal 2021 was -$1.82M.
  • ROCKWELL MEDICAL, INC. increase (decrease) in other operating assets for fiscal 2020 was -$76.00K.
Period endIncrease (Decrease) in Other Operating Assets 3 monthIncrease (Decrease) in Other Operating Assets 6 monthIncrease (Decrease) in Other Operating Assets 9 monthIncrease (Decrease) in Other Operating Assets 12 monthIncrease (Decrease) in Other Operating Assets 12 month as first filed
2023-12-31-$1.41M
10-K · filed 2024-03-21
2022-12-31-$2.72M
10-K · filed 2024-03-21
2021-12-31-$1.82M
10-K · filed 2023-03-30
2020-12-31-$76.00K
10-K · filed 2022-04-08
2019-12-31-$3.15K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$808.25K
derived: sum of 2 quarters · filed 2021-03-31
-$730.02K
derived: sum of 3 quarters · filed 2021-03-31
-$934.00K
10-K · filed 2021-03-31
-$933.96K
10-K · filed 2020-03-17
2019-09-30-$805.10K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$726.87K
derived: sum of 2 quarters · filed 2019-11-12
-$930.85K
10-Q · filed 2019-11-12
-$689.57K
derived: sum of 4 quarters · filed 2020-03-17
2019-06-30$78.23K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$125.75K
10-Q · filed 2019-08-09
$115.53K
derived: sum of 3 quarters · filed 2020-03-17
-$651.18K
derived: sum of 4 quarters · filed 2020-03-17
2019-03-31-$203.98K
10-Q · filed 2019-05-10
$37.30K
derived: sum of 2 quarters · filed 2020-03-17
-$729.41K
derived: sum of 3 quarters · filed 2020-03-17
$200.17K
derived: sum of 4 quarters · filed 2020-03-17
2018-12-31$241.28K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
-$525.43K
derived: sum of 2 quarters · filed 2020-03-17
$404.15K
derived: sum of 3 quarters · filed 2020-03-17
$165.71K
10-K · filed 2020-03-17
2018-09-30-$766.71K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$162.87K
derived: sum of 2 quarters · filed 2019-11-12
-$75.57K
10-Q · filed 2019-11-12
-$115.91K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$929.58K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$691.14K
10-Q · filed 2019-08-09
$650.80K
derived: sum of 3 quarters · filed 2019-08-09
$775.54K
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$238.44K
10-Q · filed 2019-05-10
-$278.78K
derived: sum of 2 quarters · filed 2019-05-10
-$154.03K
derived: sum of 3 quarters · filed 2019-05-10
-$343.01K
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$40.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$84.40K
derived: sum of 2 quarters · filed 2019-03-18
-$104.57K
derived: sum of 3 quarters · filed 2019-03-18
-$264.98K
10-K · filed 2019-03-18
2017-09-30$124.74K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$64.23K
derived: sum of 2 quarters · filed 2018-11-09
-$224.63K
10-Q · filed 2018-11-09
-$370.59K
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$188.97K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-14
-$349.38K
10-Q · filed 2018-08-14
-$495.34K
derived: sum of 3 quarters · filed 2018-08-14
$826.57K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$160.41K
10-Q/A · filed 2018-08-14
-$306.36K
derived: sum of 2 quarters · filed 2018-08-14
$1.02M
derived: sum of 3 quarters · filed 2018-08-14
$1.03M
derived: sum of 4 quarters · filed 2018-08-14
2016-12-31-$145.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$1.18M
derived: sum of 2 quarters · filed 2018-03-15
$1.19M
derived: sum of 3 quarters · filed 2018-03-15
$1.23M
10-K · filed 2018-03-15
2016-09-30$1.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$1.33M
derived: sum of 2 quarters · filed 2017-11-08
$1.38M
10-Q · filed 2017-11-08
$722.34K
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$11.40K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$54.13K
10-Q · filed 2017-08-09
-$599.57K
derived: sum of 3 quarters · filed 2018-03-15
$75.48K
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$42.73K
10-Q · filed 2017-05-09
-$610.97K
derived: sum of 2 quarters · filed 2018-03-15
$64.08K
derived: sum of 3 quarters · filed 2018-03-15
$176.74K
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31-$653.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$21.35K
derived: sum of 2 quarters · filed 2018-03-15
$134.00K
derived: sum of 3 quarters · filed 2018-03-15
$360.30K
10-K · filed 2018-03-15
2015-09-30$675.05K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$787.71K
derived: sum of 2 quarters · filed 2016-11-07
$1.01M
10-Q · filed 2016-11-07
$710.28K
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$112.65K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$338.95K
10-Q · filed 2016-08-09
$35.23K
derived: sum of 3 quarters · filed 2017-03-15
-$2.04M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$226.30K
10-Q · filed 2016-05-10
-$77.43K
derived: sum of 2 quarters · filed 2017-03-15
-$2.15M
derived: sum of 3 quarters · filed 2017-03-15
-$4.17K
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31-$303.73K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$2.38M
derived: sum of 2 quarters · filed 2017-03-15
-$230.47K
derived: sum of 3 quarters · filed 2017-03-15
$13.47K
10-K · filed 2017-03-15
2014-09-30-$2.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$73.26K
derived: sum of 2 quarters · filed 2015-11-09
$317.19K
10-Q · filed 2015-11-09
$253.56K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$2.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
$2.39M
10-Q · filed 2015-08-04
$2.33M
derived: sum of 3 quarters · filed 2016-02-29
$2.25M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$243.94K
10-Q · filed 2015-05-07
$180.30K
derived: sum of 2 quarters · filed 2016-02-29
$102.91K
derived: sum of 3 quarters · filed 2016-02-29
-$168.50K
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$63.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$141.03K
derived: sum of 2 quarters · filed 2016-02-29
-$412.43K
derived: sum of 3 quarters · filed 2016-02-29
-$669.90K
10-K · filed 2016-02-29
2013-09-30-$77.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$348.80K
derived: sum of 2 quarters · filed 2014-11-10
-$606.26K
10-Q · filed 2014-11-10
-$1.23M
derived: sum of 4 quarters · filed 2015-03-03
2013-06-30-$271.40K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
-$528.87K
10-Q · filed 2014-07-31
-$1.15M
derived: sum of 3 quarters · filed 2015-03-03
-$1.62M
derived: sum of 4 quarters · filed 2015-03-03
2013-03-31-$257.46K
10-Q · filed 2014-05-12
-$879.66K
derived: sum of 2 quarters · filed 2015-03-03
-$1.35M
derived: sum of 3 quarters · filed 2015-03-03
-$1.87M
derived: sum of 4 quarters · filed 2015-03-03
2012-12-31-$622.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03
-$1.10M
derived: sum of 2 quarters · filed 2015-03-03
-$1.61M
derived: sum of 3 quarters · filed 2015-03-03
-$1.86M
10-K · filed 2015-03-03
2012-09-30-$473.63K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
-$992.75K
derived: sum of 2 quarters · filed 2013-11-05
-$1.23M
10-Q · filed 2013-11-05
-$1.23M
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30-$519.13K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
-$759.97K
10-Q · filed 2013-08-01
-$760.57K
derived: sum of 3 quarters · filed 2014-03-07
$762.86K
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31-$240.84K
10-Q · filed 2013-05-08
-$241.44K
derived: sum of 2 quarters · filed 2014-03-07
$1.28M
derived: sum of 3 quarters · filed 2014-03-07
-$109.46K
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31-$600.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
$1.52M
derived: sum of 2 quarters · filed 2014-03-07
$131.38K
derived: sum of 3 quarters · filed 2014-03-07
$2.46M
10-K · filed 2014-03-07
2011-09-30$1.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$131.98K
derived: sum of 2 quarters · filed 2012-11-09
$2.46M
10-Q · filed 2012-11-09
$2.63M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$1.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$934.55K
10-Q · filed 2012-08-07
$1.11M
derived: sum of 3 quarters · filed 2013-03-18
$1.50M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$2.33M
10-Q · filed 2012-05-07
$2.50M
derived: sum of 2 quarters · filed 2013-03-18
$2.90M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$176.51K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$569.41K
derived: sum of 2 quarters · filed 2013-03-18
$690.75K
10-K · filed 2013-03-18
2010-09-30$392.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$514.24K
10-Q · filed 2011-11-04
2010-06-30$121.34K
10-Q · filed 2011-08-05
2009-12-31-$68.13K
10-K · filed 2012-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BriaCell Therapeutics Corp. (BCTX)$0.037B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
NANOVIRICIDES, INC. (NNVC)United States$0.031B